organic compounds\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890

Low-temperature study of a new nevirapine pseudopolymorph

aInstituto de Física de São Carlos, Universidade de São Paulo, FFI/Grupo de Cristalografia, Avenida Trabalhador Saocarlense 400, Brazil, bAgencia Córdoba Ciencia, Córdoba, Argentina, and cDepartamento de Física, UFC, Fortaleza, CE, Brazil
*Correspondence e-mail: cecycarol@if.sc.usp.br

(Received 23 August 2007; accepted 28 August 2007; online 18 December 2007)

The title compound (systematic name: 11-cyclo­propyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one butanol 0.3-solvate), C15H14N4O·0.3C4H9OH, was crystallized in a new triclinic pseudopolymorphic form, a butanol solvate, and the crystal structure determined at 150 K. The mol­ecular conformation of this new form differs from that reported previously, although the main inter­molecular hydrogen-bond pattern remains the same. N—H⋯O hydrogen bonds [N⋯O = 2.957 (3) Å] form centrosymmetric dimers and the crystal packing of this new pseudopolymorph generates infinite channels along the b axis.

Related literature

For the crystal structure of an earlier polymorph, see: Mui et al. (1992[Mui, P. W., Jacober, S. P., Hargrave, K. D. & Adams, J. (1992). J. Med. Chem. 35, 201-202.]). For spectroscopic studies of three further polymorphs, see: Reguri & Chakka (2005[Reguri, B. R. & Chakka, R. (2005). US Patent No. 2005059653.]); World Health Organization (2005[World Health Organization (2005). International Pharmacopoeia: Monographs for Antiretrovirals (ARVs). http://www.who.int/]). For related literature, see: Ayala et al. (2007[Ayala, A. P., Siesler, H. W., Wardell, S. M. S. V., Boechat, N., Dabbene, V. & Cuffini, S. L. (2007). J. Mol. Struct. 828, 201-210.]); Ren et al. (1995[Ren, J. S., Esnouf, R., Garman, E., Somers, D., Ross, C., Kirby, I., Keeling, J., Darby, G., Jones, Y., Stuart, D. & Stammers, D. (1995). Nat. Struct. Biol. 2, 293-302.]).

[Scheme 1]

Experimental

Crystal data
  • C15H14N4O·0.3C4H10O

  • Mr = 288.54

  • Triclinic, [P \overline 1]

  • a = 7.8116 (6) Å

  • b = 8.4302 (7) Å

  • c = 12.5451 (11) Å

  • α = 84.817 (5)°

  • β = 88.415 (5)°

  • γ = 68.252 (4)°

  • V = 764.18 (11) Å3

  • Z = 2

  • Mo Kα radiation

  • μ = 0.08 mm−1

  • T = 150.0 (2) K

  • 0.47 × 0.29 × 0.07 mm

Data collection
  • Nonius KappaCCD area-detector diffractometer

  • Absorption correction: none

  • 12941 measured reflections

  • 3141 independent reflections

  • 2295 reflections with I > 2σ(I)

  • Rint = 0.100

Refinement
  • R[F2 > 2σ(F2)] = 0.075

  • wR(F2) = 0.237

  • S = 1.08

  • 3141 reflections

  • 222 parameters

  • 28 restraints

  • H-atom parameters constrained

  • Δρmax = 0.51 e Å−3

  • Δρmin = −0.24 e Å−3

Data collection: COLLECT (Nonius, 2000[Nonius (2000). COLLECT. Nonius BV, Delft, The Netherlands.]); cell refinement: SCALEPACK (Otwinowski & Minor, 1997[Otwinowski, Z. & Minor, W. (1997). Methods in Enzymology, Vol. 276, Macromolecular Crystallography, Part A, edited by C. W. Carter Jr & R. M. Sweet, pp. 307-326. New York: Academic Press.]); data reduction: SCALEPACK and DENZO (Otwinowski & Minor, 1997[Otwinowski, Z. & Minor, W. (1997). Methods in Enzymology, Vol. 276, Macromolecular Crystallography, Part A, edited by C. W. Carter Jr & R. M. Sweet, pp. 307-326. New York: Academic Press.]); program(s) used to solve structure: SHELXS97 (Sheldrick, 1997[Sheldrick, G. M. (1997). SHELXS97 and SHELXL97. University of Göttingen, Germany.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 1997[Sheldrick, G. M. (1997). SHELXS97 and SHELXL97. University of Göttingen, Germany.]); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]); software used to prepare material for publication: WinGX (Farrugia, 1999[Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.]).

Supporting information


Comment top

Nevirapine (11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2 - b:2',3'-e][1,4]diazepin-6-one) (NVP) is an antiretroviral drug that belongs to the non-nucleoside inhibitors class of the HIV-1 virus reverse transcriptase (NNRTI). Only one crystal structure is known, reported by Mui et al., in the centrosymmetric space group, P21/c (Form I) [Mui et al., 1992]. The literature also describes the existence of two polymorphs (Form II and III), useful as anti-psychotics, and one hemihydrate pseudopolymorph (Form IV). They were studied by X-ray powder diffraction, RAMAN and IR, but no crystal structure studies are available yet [World Health Organization, 2005; Reguri & Chakka, 2005]. We report here, the crystal structure of the pseudopolymorph butanol solvate of nervirapine, C15H14N4O*0.3(CH3OH), in the centrosymmetric space group P1 (Figure 1), hereafter, Form V.

As most of the NNRTIs, nevirapine displays a "butterfly like" conformation, which is also preserved in complexes with the HIV-1 reverse transcriptase [Ren et al., 1995]. Comparing the NVP conformations, it could be seen that the dihedral angle between the least square planes through the pyridine rings is 123.89 (9)°, somewhat larger than the one found by Mui et al., 121°, but still smaller than the one determined from the enzyme-inhibitor complex structure and ab initio calculations (129.22°) [Ayala et al., 2007].

An electron delocalization effect is presented by the amide moiety of the 7-membered ring, allowing this group to adopt a planar conformation with a C6—C5—N2—C4 torsion angle of -2.7 (4)° (slightly smaller than the one found for I, -4°) and to which the cyclopropyl substituent, evolving away from the molecular framework, subtends a dihedral angle of 68.5 (1)°.

The molecular superposition of I and V, calculated by minimizing the root square distance between the atoms of the 7-membered rings, shows that the main conformational differences are mainly concentrated in the cyclopropyl group, which presents C14—C13—N4—C10 and C15—C13—N4—C11 torsion angles of 81.9 (3)°, -69.9 (3)° in V, and 74.6°, -78.1° in I, respectively. In addiction, the superposition shows a small difference in conformation of the methyl substituted pyridine ring. The asymmetric unit in V is completed by the presence of a disordered butanol molecule with an occupation factor of 0.3.

The analysis of the intermolecular interaction shows that, like in I, NEV molecules are linked essentially by two N—H···O hydrogen bonds, forming centrosymmetric dimers.

It is interesting to note that the main difference between both polymorphs is related to the crystal packing: while in I the intermolecular interaction generates a close packing with flat layers of nevirapine molecules separated by less than 4.4 Å, in V the three-dimensional arrangement generates infinite channels along de b axis with a diameter of more than 10.5 Å (Figure 2). These infinite channels are filled with highly disordered molecules of butanol, and this new Nevirapine form is stable even when a solvent occupation factor as low as 30%.

These findings indicate that a wide spectrum of new nevirapine pseudopolymorphs could be generated by just changing the solvent used in the crystallization process, as long as the volume of the solvent matches the available channel volume.

Related literature top

For the crystal structure of an earlier polymorph, see: Mui et al. (1992). For spectroscopic studies of three further polymorphs, see: Reguri & Chakka (2005); World Health Organization (2005). For related literature, see: Ayala et al. (2007); Ren et al. (1995).

Experimental top

NVP raw materials from different commercial sources were analyzed. USP standards of anhydrous and hemihydrate NEV were used as references.

Refinement top

All the hydrogen atoms were observed in the difference Fourier map, but positioned stereochemically (C—H: 0.95, C—H2: 0.97, C—H3:0.96, N—H: 0.88, O—H: 0.82 Å) and allowed to ride with isotropic displacement factors tied to those of their hosts by a factor of 1.2 (C—H, C—H2, N—H) and 1.5 (C—H3, O—H).

Structure description top

Nevirapine (11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2 - b:2',3'-e][1,4]diazepin-6-one) (NVP) is an antiretroviral drug that belongs to the non-nucleoside inhibitors class of the HIV-1 virus reverse transcriptase (NNRTI). Only one crystal structure is known, reported by Mui et al., in the centrosymmetric space group, P21/c (Form I) [Mui et al., 1992]. The literature also describes the existence of two polymorphs (Form II and III), useful as anti-psychotics, and one hemihydrate pseudopolymorph (Form IV). They were studied by X-ray powder diffraction, RAMAN and IR, but no crystal structure studies are available yet [World Health Organization, 2005; Reguri & Chakka, 2005]. We report here, the crystal structure of the pseudopolymorph butanol solvate of nervirapine, C15H14N4O*0.3(CH3OH), in the centrosymmetric space group P1 (Figure 1), hereafter, Form V.

As most of the NNRTIs, nevirapine displays a "butterfly like" conformation, which is also preserved in complexes with the HIV-1 reverse transcriptase [Ren et al., 1995]. Comparing the NVP conformations, it could be seen that the dihedral angle between the least square planes through the pyridine rings is 123.89 (9)°, somewhat larger than the one found by Mui et al., 121°, but still smaller than the one determined from the enzyme-inhibitor complex structure and ab initio calculations (129.22°) [Ayala et al., 2007].

An electron delocalization effect is presented by the amide moiety of the 7-membered ring, allowing this group to adopt a planar conformation with a C6—C5—N2—C4 torsion angle of -2.7 (4)° (slightly smaller than the one found for I, -4°) and to which the cyclopropyl substituent, evolving away from the molecular framework, subtends a dihedral angle of 68.5 (1)°.

The molecular superposition of I and V, calculated by minimizing the root square distance between the atoms of the 7-membered rings, shows that the main conformational differences are mainly concentrated in the cyclopropyl group, which presents C14—C13—N4—C10 and C15—C13—N4—C11 torsion angles of 81.9 (3)°, -69.9 (3)° in V, and 74.6°, -78.1° in I, respectively. In addiction, the superposition shows a small difference in conformation of the methyl substituted pyridine ring. The asymmetric unit in V is completed by the presence of a disordered butanol molecule with an occupation factor of 0.3.

The analysis of the intermolecular interaction shows that, like in I, NEV molecules are linked essentially by two N—H···O hydrogen bonds, forming centrosymmetric dimers.

It is interesting to note that the main difference between both polymorphs is related to the crystal packing: while in I the intermolecular interaction generates a close packing with flat layers of nevirapine molecules separated by less than 4.4 Å, in V the three-dimensional arrangement generates infinite channels along de b axis with a diameter of more than 10.5 Å (Figure 2). These infinite channels are filled with highly disordered molecules of butanol, and this new Nevirapine form is stable even when a solvent occupation factor as low as 30%.

These findings indicate that a wide spectrum of new nevirapine pseudopolymorphs could be generated by just changing the solvent used in the crystallization process, as long as the volume of the solvent matches the available channel volume.

For the crystal structure of an earlier polymorph, see: Mui et al. (1992). For spectroscopic studies of three further polymorphs, see: Reguri & Chakka (2005); World Health Organization (2005). For related literature, see: Ayala et al. (2007); Ren et al. (1995).

Computing details top

Data collection: COLLECT (Nonius, 2000); cell refinement: SCALEPACK (Otwinowski & Minor, 1997); data reduction: SCALEPACK (Otwinowski & Minor, 1997) and DENZO (Otwinowski & Minor, 1997); program(s) used to solve structure: SHELXS97 (Sheldrick, 1997); program(s) used to refine structure: SHELXL97 (Sheldrick, 1997); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997); software used to prepare material for publication: WinGX (Farrugia, 1999).

Figures top
[Figure 1] Fig. 1. The molecular structure of the butanol solvate of Nervirapine, showing the atom-labelling scheme. Displacement ellipsoids are drawn at the 30% probability level. H atoms are represented as small spheres of arbitrary radius.
[Figure 2] Fig. 2. Crystal packing of nevirapine, a) flat chain disposition of the molecules in Form I, and b) Channel formation with the solvent molecules inside.
[Figure 3] Fig. 3. Supplementary figure.
11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2 - b:2',3'-e][1,4] diazepin-6-one butanol 0.3-solvate top
Crystal data top
C15H14N4O·0.3C4H10OZ = 2
Mr = 288.54F(000) = 305.2
Triclinic, P1Dx = 1.254 Mg m3
Hall symbol: -P 1Mo Kα radiation, λ = 0.71073 Å
a = 7.8116 (6) ÅCell parameters from 37940 reflections
b = 8.4302 (7) Åθ = 2.9–26.4°
c = 12.5451 (11) ŵ = 0.08 mm1
α = 84.817 (5)°T = 150 K
β = 88.415 (5)°Prism, colourless
γ = 68.252 (4)°0.47 × 0.29 × 0.07 mm
V = 764.18 (11) Å3
Data collection top
Nonius KappaCCD area-detector
diffractometer
2295 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tubeRint = 0.100
Horizonally mounted graphite crystal monochromatorθmax = 26.8°, θmin = 3.4°
Detector resolution: 9 pixels mm-1h = 99
φ scans and ω scans winth κ offsetsk = 1010
12941 measured reflectionsl = 1515
3141 independent reflections
Refinement top
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.075H-atom parameters constrained
wR(F2) = 0.237 w = 1/[σ2(Fo2) + (0.1266P)2 + 0.361P]
where P = (Fo2 + 2Fc2)/3
S = 1.08(Δ/σ)max < 0.001
3141 reflectionsΔρmax = 0.51 e Å3
222 parametersΔρmin = 0.24 e Å3
28 restraintsExtinction correction: SHELXL97 (Sheldrick, 1997), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
Primary atom site location: structure-invariant direct methodsExtinction coefficient: 0.37 (8)
Crystal data top
C15H14N4O·0.3C4H10Oγ = 68.252 (4)°
Mr = 288.54V = 764.18 (11) Å3
Triclinic, P1Z = 2
a = 7.8116 (6) ÅMo Kα radiation
b = 8.4302 (7) ŵ = 0.08 mm1
c = 12.5451 (11) ÅT = 150 K
α = 84.817 (5)°0.47 × 0.29 × 0.07 mm
β = 88.415 (5)°
Data collection top
Nonius KappaCCD area-detector
diffractometer
2295 reflections with I > 2σ(I)
12941 measured reflectionsRint = 0.100
3141 independent reflections
Refinement top
R[F2 > 2σ(F2)] = 0.07528 restraints
wR(F2) = 0.237H-atom parameters constrained
S = 1.08Δρmax = 0.51 e Å3
3141 reflectionsΔρmin = 0.24 e Å3
222 parameters
Special details top

Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.

Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) top
xyzUiso*/UeqOcc. (<1)
C10.1486 (4)1.0251 (4)0.1362 (2)0.0486 (7)
H10.08431.12220.08870.058*
C20.2621 (4)1.0419 (4)0.2131 (2)0.0484 (7)
H20.27731.14810.21620.058*
C30.3543 (4)0.9043 (3)0.2859 (2)0.0446 (7)
C40.3290 (4)0.7507 (3)0.27637 (19)0.0413 (6)
C50.4871 (4)0.4427 (3)0.3419 (2)0.0429 (7)
C60.4937 (4)0.3825 (3)0.23304 (19)0.0412 (6)
C70.6468 (4)0.2423 (3)0.2073 (2)0.0445 (7)
H70.74700.19280.25630.053*
C80.6523 (4)0.1755 (4)0.1104 (2)0.0483 (7)
H80.75720.08190.09020.058*
C90.5019 (4)0.2482 (4)0.0438 (2)0.0473 (7)
H90.50580.20100.02260.057*
C100.3470 (4)0.4485 (3)0.15882 (19)0.0398 (6)
C110.2150 (4)0.7433 (3)0.19405 (19)0.0408 (6)
C120.4723 (5)0.9217 (4)0.3731 (2)0.0544 (8)
H12A0.48621.03280.36130.082*
H12B0.59390.82940.37250.082*
H12C0.41380.91420.44250.082*
C130.0187 (4)0.6077 (3)0.1266 (2)0.0427 (6)
H130.01560.63330.04710.051*
C140.0852 (4)0.4999 (4)0.1721 (2)0.0513 (7)
H14A0.03270.41950.23580.062*
H14B0.15220.45950.12160.062*
C150.1544 (4)0.6888 (4)0.1854 (2)0.0550 (8)
H15A0.26430.76430.14330.066*
H15B0.14480.72440.25730.066*
N10.1247 (3)0.8771 (3)0.12553 (17)0.0447 (6)
N20.4074 (3)0.6114 (3)0.35485 (16)0.0438 (6)
H2A0.40330.63900.42110.053*
N30.3494 (3)0.3815 (3)0.06598 (17)0.0438 (6)
N40.1863 (3)0.5888 (3)0.18231 (16)0.0406 (6)
O10.5584 (3)0.3371 (2)0.41782 (15)0.0558 (6)
O1S0.0302 (14)0.767 (2)0.4857 (14)0.151 (2)0.30
H1S0.13890.81620.50060.227*0.30
C1S0.0352 (18)0.1631 (17)0.4483 (10)0.080 (3)0.30
H11S0.16190.21660.42620.120*0.30
H12S0.02450.07990.50770.120*0.30
H13S0.03770.10740.38990.120*0.30
C2S0.036 (2)0.2730 (18)0.4746 (9)0.066 (3)0.30
H21S0.16250.19440.48720.079*0.30
H22S0.01750.27820.54540.079*0.30
C3S0.0709 (18)0.419 (2)0.4881 (14)0.109 (6)0.30
H31S0.18760.37030.52630.131*0.30
H32S0.10550.43420.41410.131*0.30
C4S0.019 (2)0.578 (2)0.5080 (18)0.151 (2)0.30
H41S0.11260.55940.56200.182*0.30
H42S0.08850.58080.54940.182*0.30
Atomic displacement parameters (Å2) top
U11U22U33U12U13U23
C10.0560 (16)0.0426 (15)0.0444 (15)0.0156 (13)0.0005 (12)0.0005 (11)
C20.0591 (17)0.0413 (14)0.0469 (15)0.0208 (13)0.0056 (13)0.0067 (11)
C30.0519 (15)0.0423 (14)0.0412 (14)0.0189 (12)0.0041 (11)0.0067 (11)
C40.0494 (15)0.0394 (14)0.0346 (12)0.0155 (11)0.0021 (11)0.0050 (10)
C50.0534 (15)0.0420 (14)0.0343 (13)0.0187 (12)0.0031 (11)0.0031 (10)
C60.0527 (15)0.0400 (14)0.0340 (13)0.0209 (12)0.0010 (11)0.0029 (10)
C70.0497 (15)0.0437 (15)0.0412 (14)0.0182 (12)0.0021 (11)0.0033 (11)
C80.0508 (16)0.0484 (16)0.0445 (15)0.0160 (13)0.0013 (12)0.0082 (12)
C90.0535 (16)0.0506 (16)0.0380 (13)0.0184 (13)0.0008 (11)0.0095 (11)
C100.0468 (14)0.0399 (13)0.0353 (12)0.0193 (11)0.0013 (10)0.0029 (10)
C110.0493 (14)0.0393 (14)0.0338 (12)0.0163 (11)0.0015 (11)0.0034 (10)
C120.0700 (19)0.0494 (17)0.0504 (16)0.0285 (15)0.0023 (14)0.0087 (13)
C130.0461 (14)0.0468 (15)0.0364 (13)0.0177 (12)0.0007 (11)0.0069 (11)
C140.0552 (17)0.0576 (18)0.0460 (15)0.0259 (14)0.0021 (12)0.0076 (13)
C150.0492 (16)0.0623 (19)0.0524 (16)0.0167 (14)0.0000 (13)0.0163 (14)
N10.0514 (13)0.0425 (12)0.0396 (12)0.0172 (10)0.0010 (10)0.0023 (9)
N20.0568 (14)0.0426 (12)0.0313 (11)0.0172 (10)0.0010 (9)0.0048 (9)
N30.0512 (13)0.0453 (13)0.0353 (11)0.0179 (10)0.0004 (9)0.0063 (9)
N40.0489 (13)0.0398 (12)0.0340 (11)0.0168 (10)0.0026 (9)0.0049 (8)
O10.0797 (15)0.0442 (11)0.0369 (10)0.0150 (10)0.0094 (9)0.0014 (8)
O1S0.024 (3)0.217 (5)0.210 (5)0.017 (4)0.017 (4)0.131 (4)
C1S0.067 (6)0.095 (7)0.060 (5)0.011 (5)0.008 (5)0.007 (5)
C2S0.065 (6)0.080 (7)0.048 (5)0.026 (5)0.016 (4)0.009 (5)
C3S0.022 (5)0.171 (15)0.100 (10)0.006 (8)0.011 (6)0.017 (10)
C4S0.024 (3)0.217 (5)0.210 (5)0.017 (4)0.017 (4)0.131 (4)
Geometric parameters (Å, º) top
C1—N11.346 (3)C12—H12C0.9800
C1—C21.379 (4)C13—N41.450 (3)
C1—H10.9500C13—C151.480 (4)
C2—C31.387 (4)C13—C141.496 (4)
C2—H20.9500C13—H131.0000
C3—C41.396 (4)C14—C151.504 (4)
C3—C121.501 (4)C14—H14A0.9900
C4—C111.403 (4)C14—H14B0.9900
C4—N21.419 (3)C15—H15A0.9900
C5—O11.232 (3)C15—H15B0.9900
C5—N21.347 (3)N2—H2A0.8800
C5—C61.493 (3)O1S—C4S1.497 (17)
C6—C71.390 (4)O1S—H1S0.8200
C6—C101.408 (4)C1S—C2S1.315 (15)
C7—C81.379 (4)C1S—H11S0.9600
C7—H70.9500C1S—H12S0.9600
C8—C91.372 (4)C1S—H13S0.9600
C8—H80.9500C2S—C3S1.380 (16)
C9—N31.343 (4)C2S—H21S0.9700
C9—H90.9500C2S—H22S0.9700
C10—N31.336 (3)C3S—C4S1.293 (15)
C10—N41.416 (3)C3S—H31S0.9700
C11—N11.333 (3)C3S—H32S0.9700
C11—N41.422 (3)C4S—H41S0.9700
C12—H12A0.9800C4S—H42S0.9700
C12—H12B0.9800
N1—C1—C2122.9 (3)C13—C14—C1559.12 (19)
N1—C1—H1118.5C13—C14—H14A117.9
C2—C1—H1118.5C15—C14—H14A117.9
C1—C2—C3120.3 (3)C13—C14—H14B117.9
C1—C2—H2119.9C15—C14—H14B117.9
C3—C2—H2119.9H14A—C14—H14B115.0
C2—C3—C4117.3 (2)C13—C15—C1460.19 (19)
C2—C3—C12121.2 (2)C13—C15—H15A117.8
C4—C3—C12121.4 (2)C14—C15—H15A117.8
C3—C4—C11118.7 (2)C13—C15—H15B117.8
C3—C4—N2119.2 (2)C14—C15—H15B117.8
C11—C4—N2122.0 (2)H15A—C15—H15B114.9
O1—C5—N2121.4 (2)C11—N1—C1117.2 (2)
O1—C5—C6119.2 (2)C5—N2—C4129.0 (2)
N2—C5—C6119.5 (2)C5—N2—H2A115.5
C7—C6—C10117.9 (2)C4—N2—H2A115.5
C7—C6—C5117.8 (2)C10—N3—C9117.1 (2)
C10—C6—C5123.9 (2)C10—N4—C11114.7 (2)
C8—C7—C6119.6 (3)C10—N4—C13116.68 (19)
C8—C7—H7120.2C11—N4—C13115.8 (2)
C6—C7—H7120.2C4S—O1S—H1S108.6
C9—C8—C7118.0 (3)C2S—C1S—H11S113.2
C9—C8—H8121.0C2S—C1S—H12S109.4
C7—C8—H8121.0H11S—C1S—H12S109.5
N3—C9—C8124.6 (2)C2S—C1S—H13S105.8
N3—C9—H9117.7H11S—C1S—H13S109.5
C8—C9—H9117.7H12S—C1S—H13S109.5
N3—C10—C6122.8 (2)C1S—C2S—C3S164.8 (16)
N3—C10—N4117.1 (2)C1S—C2S—H21S98.8
C6—C10—N4120.1 (2)C3S—C2S—H21S95.5
N1—C11—C4123.5 (2)C1S—C2S—H22S92.2
N1—C11—N4116.4 (2)C3S—C2S—H22S89.7
C4—C11—N4120.1 (2)H21S—C2S—H22S103.2
C3—C12—H12A109.5C4S—C3S—C2S152.3 (18)
C3—C12—H12B109.5C4S—C3S—H31S100.9
H12A—C12—H12B109.5C2S—C3S—H31S100.7
C3—C12—H12C109.5C4S—C3S—H32S97.0
H12A—C12—H12C109.5C2S—C3S—H32S94.3
H12B—C12—H12C109.5H31S—C3S—H32S104.1
N4—C13—C15115.3 (2)C3S—C4S—O1S158.0 (19)
N4—C13—C14116.6 (2)C3S—C4S—H41S95.7
C15—C13—C1460.7 (2)O1S—C4S—H41S97.1
N4—C13—H13117.3C3S—C4S—H42S96.0
C15—C13—H13117.3O1S—C4S—H42S98.3
C14—C13—H13117.3H41S—C4S—H42S103.6
N1—C1—C2—C31.8 (4)C4—C11—N1—C11.1 (4)
C1—C2—C3—C41.0 (4)N4—C11—N1—C1179.3 (2)
C1—C2—C3—C12177.4 (3)C2—C1—N1—C110.7 (4)
C2—C3—C4—C110.7 (4)O1—C5—N2—C4175.9 (3)
C12—C3—C4—C11179.1 (2)C6—C5—N2—C42.5 (4)
C2—C3—C4—N2174.4 (2)C3—C4—N2—C5141.5 (3)
C12—C3—C4—N24.0 (4)C11—C4—N2—C543.5 (4)
O1—C5—C6—C732.6 (4)C6—C10—N3—C91.6 (4)
N2—C5—C6—C7145.8 (3)N4—C10—N3—C9179.9 (2)
O1—C5—C6—C10141.0 (3)C8—C9—N3—C101.1 (4)
N2—C5—C6—C1040.5 (4)N3—C10—N4—C11118.4 (2)
C10—C6—C7—C81.5 (4)C6—C10—N4—C1163.2 (3)
C5—C6—C7—C8175.6 (2)N3—C10—N4—C1321.7 (3)
C6—C7—C8—C91.9 (4)C6—C10—N4—C13156.7 (2)
C7—C8—C9—N30.6 (4)N1—C11—N4—C10119.0 (2)
C7—C6—C10—N30.3 (4)C4—C11—N4—C1062.8 (3)
C5—C6—C10—N3173.4 (2)N1—C11—N4—C1321.5 (3)
C7—C6—C10—N4178.6 (2)C4—C11—N4—C13156.7 (2)
C5—C6—C10—N44.9 (4)C15—C13—N4—C10150.4 (2)
C3—C4—C11—N11.9 (4)C14—C13—N4—C1082.0 (3)
N2—C4—C11—N1173.1 (2)C15—C13—N4—C1170.0 (3)
C3—C4—C11—N4179.9 (2)C14—C13—N4—C11138.3 (2)
N2—C4—C11—N44.9 (4)C1S—C2S—C3S—C4S41 (7)
N4—C13—C14—C15105.5 (3)C2S—C3S—C4S—O1S105 (6)
N4—C13—C15—C14107.6 (3)
Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
N2—H2A···O1i0.88Missing2.957 (3)Missing
Symmetry code: (i) x, y, z.

Experimental details

Crystal data
Chemical formulaC15H14N4O·0.3C4H10O
Mr288.54
Crystal system, space groupTriclinic, P1
Temperature (K)150
a, b, c (Å)7.8116 (6), 8.4302 (7), 12.5451 (11)
α, β, γ (°)84.817 (5), 88.415 (5), 68.252 (4)
V3)764.18 (11)
Z2
Radiation typeMo Kα
µ (mm1)0.08
Crystal size (mm)0.47 × 0.29 × 0.07
Data collection
DiffractometerNonius KappaCCD area-detector
Absorption correction
No. of measured, independent and
observed [I > 2σ(I)] reflections
12941, 3141, 2295
Rint0.100
(sin θ/λ)max1)0.634
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.075, 0.237, 1.08
No. of reflections3141
No. of parameters222
No. of restraints28
H-atom treatmentH-atom parameters constrained
Δρmax, Δρmin (e Å3)0.51, 0.24

Computer programs: COLLECT (Nonius, 2000), SCALEPACK (Otwinowski & Minor, 1997) and DENZO (Otwinowski & Minor, 1997), SHELXS97 (Sheldrick, 1997), SHELXL97 (Sheldrick, 1997), ORTEP-3 for Windows (Farrugia, 1997), WinGX (Farrugia, 1999).

Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
N2—H2A···O1i0.88Missing2.957 (3)Missing
Symmetry code: (i) x, y, z.
 

Acknowledgements

This study was supported by CNPq, CAPES and UNESCO. The authors thanks Maribel Ferro for help in the crystallization process.

References

First citationAyala, A. P., Siesler, H. W., Wardell, S. M. S. V., Boechat, N., Dabbene, V. & Cuffini, S. L. (2007). J. Mol. Struct. 828, 201–210.  Web of Science CrossRef CAS Google Scholar
First citationFarrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  CrossRef IUCr Journals Google Scholar
First citationFarrugia, L. J. (1999). J. Appl. Cryst. 32, 837–838.  CrossRef CAS IUCr Journals Google Scholar
First citationMui, P. W., Jacober, S. P., Hargrave, K. D. & Adams, J. (1992). J. Med. Chem. 35, 201–202.  CSD CrossRef PubMed CAS Web of Science Google Scholar
First citationNonius (2000). COLLECT. Nonius BV, Delft, The Netherlands.  Google Scholar
First citationOtwinowski, Z. & Minor, W. (1997). Methods in Enzymology, Vol. 276, Macromolecular Crystallography, Part A, edited by C. W. Carter Jr & R. M. Sweet, pp. 307–326. New York: Academic Press.  Google Scholar
First citationReguri, B. R. & Chakka, R. (2005). US Patent No. 2005059653.  Google Scholar
First citationRen, J. S., Esnouf, R., Garman, E., Somers, D., Ross, C., Kirby, I., Keeling, J., Darby, G., Jones, Y., Stuart, D. & Stammers, D. (1995). Nat. Struct. Biol. 2, 293–302.  CrossRef CAS PubMed Web of Science Google Scholar
First citationSheldrick, G. M. (1997). SHELXS97 and SHELXL97. University of Göttingen, Germany.  Google Scholar
First citationWorld Health Organization (2005). International Pharmacopoeia: Monographs for Antiretrovirals (ARVs). http://www.who.int/  Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds